Clinical Trials in the Era of Treatment Tailoring

作者： P. Therasse , J. Bogaerts

DOI: 10.1007/978-3-540-28266-2_46

关键词:

摘要:

springer.com 本地加速

sci-hub.st HTML 下载加速

参考文章(40)

M Piccart, A Goldhirsch, C Straehle, The Breast International Group European Journal of Cancer. ,vol. 36, pp. 1733- 1736 ,(2000) , 10.1016/S0959-8049(00)00164-7

Gary S Gray, Jeffrey S Ross, Targeted therapy for cancer: the HER-2/neu and Herceptin story. Clinical leadership & management review : the journal of CLMA. ,vol. 17, pp. 333- 340 ,(2003)

Early Breast Cancer Trialists' Collaborative Group, None, Polychemotherapy for early breast cancer: an overview of the randomised trials The Lancet. ,vol. 352, pp. 930- 942 ,(1998) , 10.1016/S0140-6736(98)03301-7

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. The Lancet. ,vol. 359, pp. 2131- 2139 ,(2002) , 10.1016/S0140-6736(02)09088-8

Soonmyung Paik, Clinical trial methods to discover and validate predictive markers for treatment response in cancer. Biotechnology annual review. ,vol. 9, pp. 259- 267 ,(2003) , 10.1016/S1387-2656(03)09005-7

Tamoxifen for early breast cancer: An overview of the randomised trials The Lancet. ,vol. 351, pp. 1451- 1467 ,(1998) , 10.1016/S0140-6736(97)11423-4

Melvyn S. Tockman, Prabodh K. Gupta, James L. Mulshine, Norman J. Pressman, Considerations in bringing a cancer biomarker to clinical application. Cancer Research. ,vol. 52, ,(1992)

B A Gusterson, R D Gelber, A Goldhirsch, K N Price, J Säve-Söderborgh, R Anbazhagan, J Styles, C M Rudenstam, R Golouh, R Reed, Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. Journal of Clinical Oncology. ,vol. 10, pp. 1049- 1056 ,(1992) , 10.1200/JCO.1992.10.7.1049

S Paik, R Hazan, E R Fisher, R E Sass, B Fisher, C Redmond, J Schlessinger, M E Lippman, C R King, Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. Journal of Clinical Oncology. ,vol. 8, pp. 103- 112 ,(1990) , 10.1200/JCO.1990.8.1.103

Leisha A. Emens, Nancy E. Davidson, Adjuvant hormonal therapy for premenopausal women with breast cancer Clinical Cancer Research. ,vol. 9, ,(2003)